EE04090B1 - 7-(2-oksa-5,8-diasabitsüklo[4.3.0]non-8-üül) kinoloonkarboksüülhappe ja -naftüridoonkarboksüülhappederivaadid kasutamiseks Helicobacter pylori infektsioonide ja nendega kaasnevate gastroduodenaalsetehaiguste raviks - Google Patents

7-(2-oksa-5,8-diasabitsüklo[4.3.0]non-8-üül) kinoloonkarboksüülhappe ja -naftüridoonkarboksüülhappederivaadid kasutamiseks Helicobacter pylori infektsioonide ja nendega kaasnevate gastroduodenaalsetehaiguste raviks

Info

Publication number: EE04090B1
Authority: EE; Estonia
Prior art keywords: carboxylic acid; oxa; diazabicyclo; helicobacter pylori; treatment
Prior art date: 1996-12-16

Application number

EEP199900248A

Other languages

English (en)

Estonian (et)

Other versions

EE9900248A (et

Inventor

Matzke Michael

Petersen Uwe

Jaetsch Thomas

Bartel Stephan

Schenke Thomas

Himmler Thomas

Baasner Bernd

Werling Hans-Otto

Schaller Klaus

Labischinski Harald

Original Assignee

Bayer Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-16

Filing date

1997-12-04

Publication date

2003-08-15

1997-12-04 Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft

1999-12-15 Publication of EE9900248A publication Critical patent/EE9900248A/xx

2003-08-15 Publication of EE04090B1 publication Critical patent/EE04090B1/xx

Links

206010019375 Helicobacter infections Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
-1 naphthyridone carboxylic acid derivatives Chemical class 0.000 title abstract 2
HBOHUPRFLRTLDQ-UHFFFAOYSA-N 7-(3,4,4a,5,7,7a-hexahydro-2h-pyrrolo[3,4-b][1,4]oxazin-6-yl)-2-oxo-1h-quinoline-3-carboxylic acid Chemical compound C1C2NCCOC2CN1C1=CC=C2C=C(C(=O)O)C(=O)NC2=C1 HBOHUPRFLRTLDQ-UHFFFAOYSA-N 0.000 title 1
201000010099 disease Diseases 0.000 title 1
239000002253 acid Substances 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

EEP199900248A 1996-12-16 1997-12-04 7-(2-oksa-5,8-diasabitsüklo[4.3.0]non-8-üül) kinoloonkarboksüülhappe ja -naftüridoonkarboksüülhappederivaadid kasutamiseks Helicobacter pylori infektsioonide ja nendega kaasnevate gastroduodenaalsetehaiguste raviks EE04090B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19652239A DE19652239A1 (de)	1996-12-16	1996-12-16	Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
PCT/EP1997/006781 WO1998026779A1 (fr)	1996-12-16	1997-12-04	Utilisation de derives d'acide 7-(2-oxy-5,8-diazabicyclo[4.3.0]non-8-yl)quinoleone et naphtyridonecarboxylique pour le traitement d'infections par helicobacter pylori et des maladies gastro-duodenales qui y sont associees

Publications (2)

Publication Number	Publication Date
EE9900248A EE9900248A (et)	1999-12-15
EE04090B1 true EE04090B1 (et)	2003-08-15

Family

ID=7814837

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP199900248A EE04090B1 (et)	1996-12-16	1997-12-04	7-(2-oksa-5,8-diasabitsüklo[4.3.0]non-8-üül) kinoloonkarboksüülhappe ja -naftüridoonkarboksüülhappederivaadid kasutamiseks Helicobacter pylori infektsioonide ja nendega kaasnevate gastroduodenaalsetehaiguste raviks

Country Status (27)

Country	Link
US (2)	US6133260A (fr)
EP (1)	EP0946176B1 (fr)
JP (3)	JP3463939B2 (fr)
KR (1)	KR100536153B1 (fr)
CN (1)	CN100335054C (fr)
AT (1)	ATE214929T1 (fr)
AU (1)	AU717751B2 (fr)
BG (1)	BG64615B1 (fr)
BR (1)	BR9714032A (fr)
CA (1)	CA2274894C (fr)
CZ (2)	CZ297363B6 (fr)
DE (2)	DE19652239A1 (fr)
DK (1)	DK0946176T3 (fr)
EA (1)	EA002477B1 (fr)
EE (1)	EE04090B1 (fr)
ES (1)	ES2175519T3 (fr)
HU (1)	HU226523B1 (fr)
IL (1)	IL130311A (fr)
NO (1)	NO325617B1 (fr)
NZ (2)	NZ336228A (fr)
PL (1)	PL191193B1 (fr)
PT (1)	PT946176E (fr)
RS (1)	RS49684B (fr)
SK (2)	SK283223B6 (fr)
TR (1)	TR199901754T2 (fr)
UA (1)	UA57055C2 (fr)
WO (1)	WO1998026779A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19633805A1 (de) *	1996-02-23	1997-08-28	Bayer Ag	Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
ATE245140T1 (de) *	1998-11-18	2003-08-15	Asahi Glass Co Ltd	Derivate der aminoacryl-säure und ein verfahren zur herstellung derselben
DE19917617A1 (de) *	1999-04-19	2000-10-26	Bayer Ag	-(-)Enantiomeres des 2-[2-(1-Chlor-cyclopropyl)-3-(2-chlorphenyl) 2-hydroxy-propyl]-2,4-dihydro-[1,2,4]-triazol-3-thions
MXPA02000103A (es) *	1999-07-01	2003-07-21	Wakunaga Pharma Co Ltd	Derivado de acido quinolin carboxilico o sales del mismo.
HU230030B1 (hu) *	1999-10-08	2015-05-28	Debiopharm International Sa	Fab I inhibitorok
EP1560584B1 (fr) *	2001-04-06	2009-01-14	Affinium Pharmaceuticals, Inc.	Inhibiteurs de fab i
EP1575951B1 (fr) *	2002-12-06	2014-06-25	Debiopharm International SA	Composes heterocycliques, procedes de production de ceux-ci et utilisation de ceux-ci dans un traitement
WO2004082586A2 (fr)	2003-03-17	2004-09-30	Affinium Pharmaceuticals, Inc.	Compositions comportant plusieurs agents antibiotiques, et leurs procedes de mise en oeuvre
EP1669354B1 (fr)	2003-09-29	2013-03-20	Daiichi Sankyo Company, Limited	Derive d'acide 8-cyanoquinolone-carboxylique
US7759362B2 (en)	2004-04-21	2010-07-20	Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences	Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
CN1244582C (zh) *	2004-04-21	2006-03-08	中国医学科学院医药生物技术研究所	喹诺酮羧酸类化合物及其制备方法和医药用途
DK1828167T3 (da) *	2004-06-04	2014-10-20	Debiopharm Int Sa	Acrylamidderivater som antibiotiske midler
KR20080075027A (ko) *	2005-12-05	2008-08-13	아피늄 파마슈티컬스, 인크.	Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
JP5468899B2 (ja)	2006-07-20	2014-04-09	アフィニウムファーマシューティカルズ，インク．	Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP2125802A4 (fr)	2007-02-16	2014-08-20	Debiopharm Int Sa	Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
AU2010266120B2 (en)	2009-07-02	2014-02-06	Curofin Pharma Gmbh	Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
RU2449805C1 (ru)	2011-01-27	2012-05-10	Общество С Ограниченной Ответственностью "Гармония"	Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
AU2013279021C1 (en)	2012-06-19	2017-03-16	Debiopharm International Sa	Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
US9504691B2 (en) *	2012-12-06	2016-11-29	Alcon Research, Ltd.	Finafloxacin suspension compositions
US20150045739A1 (en)	2013-08-12	2015-02-12	Novartis Ag	Method for treating otic infections after tympanostomy tube placement
DE102014115951A1 (de)	2014-11-03	2016-05-04	Merlion Pharmaceuticals Pte Ltd.	Zusammensetzungen, die Finafloxacin und Tris enthalten
DE102015100068A1 (de)	2015-01-06	2016-07-07	Merlion Pharmaceuticals Pte Ltd.	Finafloxacin zur verwendung bei der behandlung von harnwegsinfektionen
RS61312B1 (sr)	2016-02-26	2021-02-26	Debiopharm Int Sa	Lek za lečenje infekcija dijabetskog stopala
CN107987074B (zh) *	2017-10-27	2020-12-29	浙江美诺华药物化学有限公司	一种普拉沙星的合成方法
JP7410050B2 (ja) *	2018-04-25	2024-01-09	バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	キノロンカルボン酸エステルの加水分解プロセス
TN2021000159A1 (en)	2019-02-14	2023-04-04	Debiopharm Int Sa	Afabicin formulation, method for making the same and uses thereof
SG11202113174SA (en)	2019-06-14	2021-12-30	Debiopharm Int Sa	Medicament and use thereof for treating bacterial infections involving biofilm

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4822801A (en) *	1984-07-20	1989-04-18	Warner-Lambert Company	4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
JPS62205060A (ja) *	1986-03-04	1987-09-09	Kyorin Pharmaceut Co Ltd	８位置換キノロンカルボン酸誘導体
DE3702393A1 (de) *	1987-01-28	1988-08-11	Bayer Ag	8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
US5563138A (en) *	1987-04-16	1996-10-08	Otsuka Pharmaceutical Company, Limited	Benzoheterocyclic compounds
US4889857A (en) *	1987-10-12	1989-12-26	Yoshitomi Pharmaceutical Industries, Ltd.	Quinolonecarboxylic acid compounds and pharmaceutical use thereof
WO1989005643A1 (fr) *	1987-12-18	1989-06-29	Pfizer Inc.	Acides carboxyliques de quinoline a substitution heterocyclique
JP2844079B2 (ja) *	1988-05-23	1999-01-06	塩野義製薬株式会社	ピリドンカルボン酸系抗菌剤
DE3906365A1 (de) *	1988-07-15	1990-01-18	Bayer Ag	7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5147873A (en) *	1988-08-23	1992-09-15	Pfizer Inc.	Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
CA2001203C (fr) *	1988-10-24	2001-02-13	Thomas P. Demuth, Jr.	Dithiocarbamoyl quinolones antimicrobiens
US5262417A (en) *	1988-12-06	1993-11-16	The Upjohn Company	Antibacterial quinolone compounds
US5407932A (en) *	1989-03-31	1995-04-18	Wakunaga Seiyaku Kabushiki Kaisha	Quinolone derivatives and antibacterial agents containing the same
DE3910663A1 (de) *	1989-04-03	1990-10-04	Bayer Ag	5-alkylchinoloncarbonsaeuren
US5252734A (en) *	1989-04-03	1993-10-12	Bayer Aktiengesellschaft	Antibacterial 5-alkylquinolonecarboxylic acids
US5140033A (en) *	1989-04-03	1992-08-18	Bayer Aktiengesellschaft	Antibacterial 5-alkylquinolonecarboxylic acids
US5164402A (en) *	1989-08-16	1992-11-17	Pfizer Inc	Azabicyclo quinolone and naphthyridinone carboxylic acids
KR910009330B1 (ko) *	1989-10-23	1991-11-11	재단법인 한국화학연구소	항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
DE4200415A1 (de)	1992-01-10	1993-07-15	Bayer Ag	Enantiomerenreine 2-oxa-5,8-diazabicyclo(4.3.0)nonane sowie verfahren zu ihrer herstellung
TW209865B (fr) *	1992-01-10	1993-07-21	Bayer Ag
CA2112165C (fr) *	1992-12-25	2003-04-08	Makoto Takemura	Derives amine bicycliques
DE4309964A1 (de)	1993-03-26	1994-09-29	Bayer Ag	Verfahren zur Herstellung enantiomerenreiner trans-2-Oxa-5,8-diazabicyclo[4.3.0]nonane
WO1994025464A1 (fr) *	1993-04-24	1994-11-10	Korea Research Institute Of Chemical Technology	Nouveaux derives d'acide quinolone-carboxylique et leur procede de preparation
US5532239A (en) *	1993-08-02	1996-07-02	Assistance Publique - Hopitaux De Paris	Therapeutic application of fluoroquinolone derivatives
DE4329600A1 (de) *	1993-09-02	1995-03-09	Bayer Ag	Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
EP0676199B1 (fr) *	1994-04-07	1998-09-02	Pfizer Inc.	Utilisation de trovafloxacine ou de ses dérivés pour la fabrication d'un médicament pour le traitement d'infections de H.pylori
GB2289674A (en) *	1994-05-23	1995-11-29	Pfizer	Antibacterial naphthyridine
JPH0848629A (ja) *	1994-08-08	1996-02-20	Dainippon Pharmaceut Co Ltd	ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤

1996
- 1996-12-16 DE DE19652239A patent/DE19652239A1/de not_active Withdrawn
1997
- 1997-04-12 UA UA99074093A patent/UA57055C2/uk unknown
- 1997-12-04 AT AT97954354T patent/ATE214929T1/de active
- 1997-12-04 DK DK97954354T patent/DK0946176T3/da active
- 1997-12-04 CZ CZ0216899A patent/CZ297363B6/cs not_active IP Right Cessation
- 1997-12-04 US US09/319,888 patent/US6133260A/en not_active Expired - Lifetime
- 1997-12-04 HU HU0000450A patent/HU226523B1/hu unknown
- 1997-12-04 DE DE59706808T patent/DE59706808D1/de not_active Expired - Lifetime
- 1997-12-04 CZ CZ20003148A patent/CZ297364B6/cs not_active IP Right Cessation
- 1997-12-04 BR BR9714032-5A patent/BR9714032A/pt not_active IP Right Cessation
- 1997-12-04 EP EP97954354A patent/EP0946176B1/fr not_active Expired - Lifetime
- 1997-12-04 CN CNB971817200A patent/CN100335054C/zh not_active Expired - Lifetime
- 1997-12-04 AU AU58541/98A patent/AU717751B2/en not_active Expired
- 1997-12-04 SK SK795-99A patent/SK283223B6/sk not_active IP Right Cessation
- 1997-12-04 NZ NZ336228A patent/NZ336228A/xx not_active IP Right Cessation
- 1997-12-04 WO PCT/EP1997/006781 patent/WO1998026779A1/fr not_active Ceased
- 1997-12-04 KR KR10-1999-7005330A patent/KR100536153B1/ko not_active Expired - Lifetime
- 1997-12-04 PT PT97954354T patent/PT946176E/pt unknown
- 1997-12-04 RS YUP-274/99A patent/RS49684B/sr unknown
- 1997-12-04 SK SK1496-2000A patent/SK283224B6/sk not_active IP Right Cessation
- 1997-12-04 EA EA199900526A patent/EA002477B1/ru not_active IP Right Cessation
- 1997-12-04 JP JP52725098A patent/JP3463939B2/ja not_active Expired - Lifetime
- 1997-12-04 ES ES97954354T patent/ES2175519T3/es not_active Expired - Lifetime
- 1997-12-04 CA CA002274894A patent/CA2274894C/fr not_active Expired - Lifetime
- 1997-12-04 IL IL13031197A patent/IL130311A/en not_active IP Right Cessation
- 1997-12-04 EE EEP199900248A patent/EE04090B1/xx unknown
- 1997-12-04 PL PL333928A patent/PL191193B1/pl unknown
- 1997-12-04 TR TR1999/01754T patent/TR199901754T2/xx unknown
1999
- 1999-06-08 BG BG103474A patent/BG64615B1/bg unknown
- 1999-06-14 NO NO19992903A patent/NO325617B1/no not_active IP Right Cessation
- 1999-11-08 US US09/436,316 patent/US6432948B1/en not_active Expired - Lifetime
2000
- 2000-05-25 JP JP2000154543A patent/JP4463380B2/ja not_active Expired - Lifetime
- 2000-08-04 NZ NZ506162A patent/NZ506162A/en not_active IP Right Cessation
2009
- 2009-07-22 JP JP2009171127A patent/JP5112395B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0946176B1 (fr)	2002-03-27
US6432948B1 (en)	2002-08-13
NO992903D0 (no)	1999-06-14
EA002477B1 (ru)	2002-06-27
TR199901754T2 (xx)	1999-09-21
JP5112395B2 (ja)	2013-01-09
DE19652239A1 (de)	1998-06-18
EE9900248A (et)	1999-12-15
JP2009235106A (ja)	2009-10-15
HK1025517A1 (zh)	2000-11-17
PL333928A1 (en)	2000-01-31
YU27499A (sh)	2002-10-18
NO992903L (no)	1999-06-14
DE59706808D1 (de)	2002-05-02
IL130311A (en)	2004-01-04
WO1998026779A1 (fr)	1998-06-25
EA199900526A1 (ru)	2000-08-28
DK0946176T3 (da)	2002-06-10
CN1245428A (zh)	2000-02-23
CN100335054C (zh)	2007-09-05
RS49684B (sr)	2007-11-15
KR20000069483A (ko)	2000-11-25
NZ336228A (en)	2000-12-22
CZ297364B6 (cs)	2006-11-15
BR9714032A (pt)	2000-05-09
NO325617B1 (no)	2008-06-30
PT946176E (pt)	2002-08-30
EP0946176A1 (fr)	1999-10-06
JP4463380B2 (ja)	2010-05-19
JP2000514825A (ja)	2000-11-07
IL130311A0 (en)	2000-06-01
SK283224B6 (sk)	2003-03-04
SK283223B6 (sk)	2003-03-04
SK79599A3 (en)	2001-01-18
CZ216899A3 (cs)	2000-02-16
KR100536153B1 (ko)	2005-12-14
NZ506162A (en)	2001-06-29
BG64615B1 (bg)	2005-09-30
PL191193B1 (pl)	2006-03-31
BG103474A (en)	2000-01-31
ATE214929T1 (de)	2002-04-15
JP2000351781A (ja)	2000-12-19
ES2175519T3 (es)	2002-11-16
CZ297363B6 (cs)	2006-11-15
HU226523B1 (en)	2009-03-30
AU717751B2 (en)	2000-03-30
AU5854198A (en)	1998-07-15
US6133260A (en)	2000-10-17
JP3463939B2 (ja)	2003-11-05
UA57055C2 (uk)	2003-06-16
SK14962000A3 (sk)	2003-01-09
CA2274894A1 (fr)	1998-06-25
CA2274894C (fr)	2009-04-07
HUP0000450A3 (en)	2001-02-28
HUP0000450A2 (hu)	2000-10-28

Legal Events

Date	Code	Title	Description
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2009-06-15	GB1A	Change in the ownership or in the address of the owner
2010-02-15	KB4A	Valid patent at the end of a year	Effective date: 20091231
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231

Publication	Publication Date	Title
EE04090B1 (et)	2003-08-15	7-(2-oksa-5,8-diasabitsüklo[4.3.0]non-8-üül) kinoloonkarboksüülhappe ja -naftüridoonkarboksüülhappederivaadid kasutamiseks Helicobacter pylori infektsioonide ja nendega kaasnevate gastroduodenaalsetehaiguste raviks
TNSN03144A1 (en)	2005-12-23	Pyrrolopyrimidines as protein kinase inhibitors
EE200100172A (et)	2002-06-17	Tetrahüdropüridoeetrid, nende kasutamine ja ravim
UY25792A1 (es)	2001-08-27	Preparado farmacéutico de moxifloxacina.
MA27566A1 (fr)	2005-10-03	Inhibiteurs de 4-oxo-1-(3-phenyle substitue -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4
FI873248A0 (fi)	1987-07-24	7-((3-(aminometyl)-3-alkyl)-1 -pyrrolidinyl)-kinolin-karboxylsyror.
NO983444D0 (no)	1998-07-24	Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
DE60111553D1 (de)	2005-07-21	Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
DK0704443T3 (da)	2001-01-29	Quinolon- og naphthyridoncarboxylsyrederivater
BR0014052A (pt)	2002-05-21	Derivados de aminas
ES542583A0 (es)	1985-12-16	Procedimiento para la preparacion de nuevos derivados de triazolopirimidina.